Skip to content

Characterization and therapeutic potential of two Kayvirus phages against methicillin-resistant S. aureus in a rat myositis model.

Jul 2026 · European Journal of Clinical Microbiology and Infectious Diseases · 0 citations · 7 references
Medicine

TL;DR

Findings demonstrate the stability, safety, and therapeutic efficacy of bacteriophages EAS1 and EAS2, particularly EAS2, supporting phage therapy as a promising alternative approach for the treatment of MRSA infections.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.